Live genetically attenuated malaria vaccine

Details for Australian Patent Application No. 2004309380 (hide)

Owner Seattle Biomedical Research Institute

Inventors Kappe, Stefan H.I.; Mueller, Ann-Kristin; Matuschewki, Kai-Uwe C.

Agent Freehills

Pub. Number AU-B-2004309380

PCT Pub. Number WO2005/063991

Priority 60/531,479 19.12.03 US; 60/631,228 26.11.04 US

Filing date 20 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 29 April 2010

International Classifications

C12N 1/11 (2006.01) Micro-organisms, e.g. protozoa

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 33/06 (2006.01) Antiparasitic agents

C07K 14/445 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/063991 Priority application(s): WO2005/063991

29 April 2010 Application Accepted

  Published as AU-B-2004309380

26 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309390-Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment

2004309379-Method and compositions for identifying anti-HIV therapeutic compounds